Category: Intellectual property
-
U.S. Patent Issued for Stem Cell Wound Care Technology
Stemedica Cell Technologies Inc. in San Diego has been granted a patent for its scaffolding technology based on adult stem cells used in healing wounds. Patent number 8,105,380 was awarded to Ludmilla and Alex Kharazi, Stemedica’s senior scientist and chief technology officer respectively, by the United States Patent and Trademark Office on 31 January 2012.…
-
Patent Awarded for Clinical Trial Molecular Matching System
The U.S. Patent and Trademark Office awarded a patent to the Moffitt Cancer Center at University of South Florida in Tampa on its system for matching patients to clinical trials based on molecular profiles of the patients and drugs. Patent number 8,095,389 was granted last month to inventors William Dalton, president of the Moffitt Cancer…
-
Stem Cells Repair Heart Muscle in Clinical Trial
A clinical trial at Cedars-Sinai Heart Institute in Los Angeles and Johns Hopkins Medical Center in Baltimore has shown that treating patients with their own heart-derived stem cells helps re-grow healthy muscle damaged by a heart attack. The team led by Raj Makkar of Cedars-Sinai using technology developed by Eduardo Marbán (pictured right), director of…
-
Instrument Company to License Scripps Screening Technology
Brooks Life Science Systems, a division of Brooks Automation in Poway, California, and Scripps Research Institute in Jupiter, Florida have agreed for Brooks to commercialize technology developed at Scripps to manage compounds in high-throughput screening, a process for drug discovery. Brooks Automation is a provider of instrumentation technology for manufacturing, energy, and life sciences companies.…
-
USPTO Competition to Boost Patents for Humanitarian Goals
The U.S. Patent and Trademark Office (USPTO) today unveiled a competition to encourage inventors to share their patented technologies to address humanitarian needs. Winning inventors will receive a faster review of their applications for patents on future inventions. The program, called Patents for Humanity, is officially a pilot program to help address an Obama administration…
-
Vibrating Microsensors Developed for Detection, Testing
Engineers at Purdue University in West Lafayette, Indiana have applied tiny vibrating microcantilevers to sensors that could detect chemical and biological substances. Their research is described in this week’s online issue of the Journal of Microelectromechanical Systems (paid subscription required), and a patent is pending on their invention. The team led by mechanical engineering professor…
-
Patent Granted for Nanotech Medical Diagnostic Technology
Medical diagnostics developer T2 Biosystems in Lexington, Massachusetts has received a U.S. patent for its sensor technology based on magnetic nanoparticles. Patent 8,102,176 was issued on 24 January by the U.S. Patent and Trademark Office to W. David Lee, a program officer at MIT’s Koch Institute for Cancer Research and a founder of T2 Biosystems.…
-
Medical Sensor Powered by Music Vibrations Developed
Engineers at Purdue University in Indiana have developed a miniature medical sensor that can be powered by vibrations from music played nearby, with the deep bass of rap music found most effective. The research conducted in the lab of Babak Ziaie, professor of electrical and computer engineering and biomedical engineering, will be presented at the…
-
Report: Asia Closing Gap in U.S. R&D Leadership
National Science Foundation’s new report on global research and development (R&D) trends, Science and Engineering Indicators 2012, shows in the last decade, U.S. leadership in research and development has come under severe challenge from China and other countries in Asia. The report from NSF’s policy-making body, the National Science Board, shows between 1999 and 2009,…
-
Novartis to Restructure, Cut 1,960 U.S. Jobs
The Swiss company Novartis Pharmaceuticals said on Friday it plans to reorganize its General Medicines division in the U.S. resulting in a loss of 1,960 jobs. The company said it expects the job cuts to take place in the second quarter of 2012. Novartis plans to reduce its General Medicines field workforce by 1,630 jobs…